Outcomes of a Specialty Pharmacy Program for Oral Oncology
... for its commercial patients in August 2007. The program required the contracted specialty pharmacy to provide clinical expertise and patient education in oncology medications and comorbid conditions, a monthly proactive adherence program including refill reminders, adherence screenings, and interven ...
... for its commercial patients in August 2007. The program required the contracted specialty pharmacy to provide clinical expertise and patient education in oncology medications and comorbid conditions, a monthly proactive adherence program including refill reminders, adherence screenings, and interven ...
Engaging patients in their healthcare
... • risk communication and involvement in treatment decisions • support for self-care and self-management. The data source for this analysis is the series of international health policy surveys conducted by the Commonwealth Fund of New York, specifically the surveys carried out in 2004 and 2005 which ...
... • risk communication and involvement in treatment decisions • support for self-care and self-management. The data source for this analysis is the series of international health policy surveys conducted by the Commonwealth Fund of New York, specifically the surveys carried out in 2004 and 2005 which ...
eMedicine - Pulmonary Embolism
... documented in the medical chart. Sadly, appropriate diagnostic and therapeutic management often is withheld even when the potential diagnosis of PE has been considered explicitly and documented in the chart. Pathophysiology: Pulmonary thromboembolism is not a disease in and of itself. Rather, it is ...
... documented in the medical chart. Sadly, appropriate diagnostic and therapeutic management often is withheld even when the potential diagnosis of PE has been considered explicitly and documented in the chart. Pathophysiology: Pulmonary thromboembolism is not a disease in and of itself. Rather, it is ...
Evaluation of the Multinational Association for Supportive Care in
... and fever of uncertain origin, based on the clinical and laboratory parameters. It is known that infection is documented only in a minority of the febrile neutropaenic patients [1]. In approximately 50% of the patients, no infection was found, in 30%, an infection was microbiologically documented (m ...
... and fever of uncertain origin, based on the clinical and laboratory parameters. It is known that infection is documented only in a minority of the febrile neutropaenic patients [1]. In approximately 50% of the patients, no infection was found, in 30%, an infection was microbiologically documented (m ...
2006 AHA Secondary Prevention Guidelines Slide Set
... HTN who had a recorded BP reading <140/90 mmHg or who were prescribed 2+ medications Denominator: Patients with HTN diagnosed for at least 6 months ...
... HTN who had a recorded BP reading <140/90 mmHg or who were prescribed 2+ medications Denominator: Patients with HTN diagnosed for at least 6 months ...
March - NABP
... oxycodone order from an extended-release formulation to an immediate release formulation at the same dose and frequency. The nurse receiving the verbal order transcribed it as “Discontinue OxyContin 10 mg BID, Start OxyContin 10 mg IR BID,” with “IR” meant to represent immediate release. Although Ox ...
... oxycodone order from an extended-release formulation to an immediate release formulation at the same dose and frequency. The nurse receiving the verbal order transcribed it as “Discontinue OxyContin 10 mg BID, Start OxyContin 10 mg IR BID,” with “IR” meant to represent immediate release. Although Ox ...
View Poster - Nivalis Therapeutics
... duration are also likely required to demonstrate any effect on inflammatory biomarkers in this stable CF population. The emergence of sweat chloride as a possible pharmacodynamic biomarker is encouraging. The sweat chloride data suggest an onset of effect at the highest dose studied. This dose provi ...
... duration are also likely required to demonstrate any effect on inflammatory biomarkers in this stable CF population. The emergence of sweat chloride as a possible pharmacodynamic biomarker is encouraging. The sweat chloride data suggest an onset of effect at the highest dose studied. This dose provi ...
COSENTYX® - Medicines.org.au
... In the subset of psoriatic arthritis patients in the ERASURE and FIXTURE studies, physical function was assessed using the HAQ Disability Index (HAQ-DI). In these studies, patients treated with 150 mg or 300 mg Cosentyx showed greater improvement from baseline in the HAQ-DI score (mean decreases of ...
... In the subset of psoriatic arthritis patients in the ERASURE and FIXTURE studies, physical function was assessed using the HAQ Disability Index (HAQ-DI). In these studies, patients treated with 150 mg or 300 mg Cosentyx showed greater improvement from baseline in the HAQ-DI score (mean decreases of ...
Clopixol-Acuphase® 50 mg/ml Zuclopenthixol acetate
... or zuclopenthixol decanoate i.m., after the following guidelines: 1) Change to oral zuclopenthixol 2 to 3 days after the last injection of zuclopenthixol acetate a patient who has been treated with 100 mg zuclopenthixol acetate, should be started at an oral dosage of about 40 mg daily, possib ...
... or zuclopenthixol decanoate i.m., after the following guidelines: 1) Change to oral zuclopenthixol 2 to 3 days after the last injection of zuclopenthixol acetate a patient who has been treated with 100 mg zuclopenthixol acetate, should be started at an oral dosage of about 40 mg daily, possib ...
atrial fibrillation - Downriver Cardiology
... this medicine is that it is just a beta-blocker. At higher doses, it takes on antiarrhythmic effects. That is, it increases the likelihood that the heart rhythm will remain normal. In patients who take this medication, the chance of a regular heart rhythm one year later is about 70%. A disadvantage ...
... this medicine is that it is just a beta-blocker. At higher doses, it takes on antiarrhythmic effects. That is, it increases the likelihood that the heart rhythm will remain normal. In patients who take this medication, the chance of a regular heart rhythm one year later is about 70%. A disadvantage ...
When Hand Hygiene after touching a patient Hand hygiene on
... Safety and Quality in Health Care Based on the World Health Organisation World Alliance for Patient Safety Campaign “Save Lives: Clean Your Hands” Some adaptation may be necessary for the Mental Health setting ...
... Safety and Quality in Health Care Based on the World Health Organisation World Alliance for Patient Safety Campaign “Save Lives: Clean Your Hands” Some adaptation may be necessary for the Mental Health setting ...
a physician`s perspective - Puget Sound Behavioral Medicine
... be tried, because some individuals tolerate them better and find them more effective. However, if the six or eight hour medication is used, a second dose should be given to allow patients to have the therapeutic benefit for the full day. SAFETY PROFILE The stimulant medications are one of the most s ...
... be tried, because some individuals tolerate them better and find them more effective. However, if the six or eight hour medication is used, a second dose should be given to allow patients to have the therapeutic benefit for the full day. SAFETY PROFILE The stimulant medications are one of the most s ...
M1: Study Overview
... fluids (2100 mL for a 70 kg patient) before enrolment OR the most responsible physician has good reasons to believe that more fluid resuscitation is no longer required and could be harmful. The treating physician believes will need vasopressors for at least 6 hours once enrolled ...
... fluids (2100 mL for a 70 kg patient) before enrolment OR the most responsible physician has good reasons to believe that more fluid resuscitation is no longer required and could be harmful. The treating physician believes will need vasopressors for at least 6 hours once enrolled ...
Economic appraisal of maintenance parenteral iron administration in
... intolerance whereas the other half did not achieve appropriate ferritin levels despite the maximal prescribed dose. Adequacy of iron absorption in uraemic patients has been a matter of controversy [8]; however, concomitant use of commonly prescribed medications such as histamine H2 blockers and phos ...
... intolerance whereas the other half did not achieve appropriate ferritin levels despite the maximal prescribed dose. Adequacy of iron absorption in uraemic patients has been a matter of controversy [8]; however, concomitant use of commonly prescribed medications such as histamine H2 blockers and phos ...
Victoria Sep 2007 presentation Brandon RHA Home Care Teams in
... • Our provincial DPIN database is not the best source to reconcile medications; in our region a better source for Home Care is pharmacy and then physician • The entire process of medication reconciliation takes time, but is worthwhile, as discrepancies are present even in blister pack medications. • ...
... • Our provincial DPIN database is not the best source to reconcile medications; in our region a better source for Home Care is pharmacy and then physician • The entire process of medication reconciliation takes time, but is worthwhile, as discrepancies are present even in blister pack medications. • ...
antiviral treatment of hepatitis c in serbian prison setting
... of our study population (one patient experienced relapse of pulmonary tuberculosis, one took an overdose of drug and one gave up on therapy). Only one patient did not achieve an early virologic response which was the reason to discontinue therapy. These results are comparable with the Duncan study a ...
... of our study population (one patient experienced relapse of pulmonary tuberculosis, one took an overdose of drug and one gave up on therapy). Only one patient did not achieve an early virologic response which was the reason to discontinue therapy. These results are comparable with the Duncan study a ...
Follicular lymphoma
... assessment (HNA) (see Appendix 5: LCA Holistic Needs Assessment Tool) at key pathway points, including within 31 days of diagnosis; at the end of each treatment regimen; and whenever a person requests one. Following each HNA, every patient should be offered a written care plan. This plan should be d ...
... assessment (HNA) (see Appendix 5: LCA Holistic Needs Assessment Tool) at key pathway points, including within 31 days of diagnosis; at the end of each treatment regimen; and whenever a person requests one. Following each HNA, every patient should be offered a written care plan. This plan should be d ...
Chronic heart failure - Pharmaceutical Journal
... including disease duration, male gender, single status, full-time employment and three times a day dosing.12 Patients gave forgetfulness, questioning the need for medication, inconvenient regimens and having to take many tablets as reasons for non-adherence. In 2009, the National Institute for Healt ...
... including disease duration, male gender, single status, full-time employment and three times a day dosing.12 Patients gave forgetfulness, questioning the need for medication, inconvenient regimens and having to take many tablets as reasons for non-adherence. In 2009, the National Institute for Healt ...
Your guide to Legacy Oregon Burn Center
... patient’s weight distribution, reduce body pressure and minimize skin and tissue damage. • Hand-held devices to analyze blood samples at the patient’s bedside within minutes. This advanced technology allows medical team members to rapidly detect and correct potentially life-threatening conditions th ...
... patient’s weight distribution, reduce body pressure and minimize skin and tissue damage. • Hand-held devices to analyze blood samples at the patient’s bedside within minutes. This advanced technology allows medical team members to rapidly detect and correct potentially life-threatening conditions th ...
DRUG PRESCRIBING PATTERN IN DERMATOLOGY IN A
... monitored intermittently in order to analyze their rationality and to offer feedback and/or suggestions to drug prescribers so as to enable and effect suitable modifications in prescribing pattern to increase the therapeutic benefits and reduce adverse effects. Collection of data on the utilization ...
... monitored intermittently in order to analyze their rationality and to offer feedback and/or suggestions to drug prescribers so as to enable and effect suitable modifications in prescribing pattern to increase the therapeutic benefits and reduce adverse effects. Collection of data on the utilization ...
Serotonin syndrome - Exeter Headache Clinic
... prescribing habits.Of the respondents 2/3 sometoimes combine injectable sumatriptan with oral sumatriptan . 30% sometimes advise patients to combine a different triptan with injectable sumatriptan and 21% do so routinely. ...
... prescribing habits.Of the respondents 2/3 sometoimes combine injectable sumatriptan with oral sumatriptan . 30% sometimes advise patients to combine a different triptan with injectable sumatriptan and 21% do so routinely. ...
Abnormal Involuntary Movement Disorders (Dyskinesias)
... frequent falls. Motor dysfunction can initially be unilateral or more commonly bilateral and asymmetrical. Rarely, patients show gait unsteadiness with no signs of parkinsonism in arms (lower-half syndrome). When only legs are involved and no tremor is present, this clinical pattern can cause diagno ...
... frequent falls. Motor dysfunction can initially be unilateral or more commonly bilateral and asymmetrical. Rarely, patients show gait unsteadiness with no signs of parkinsonism in arms (lower-half syndrome). When only legs are involved and no tremor is present, this clinical pattern can cause diagno ...
The Safety of First-Dose Home IV Antibiotic Therapy
... medically supervised setting is advocated by most health care professionals, as reflected in the 2004 practice guidelines of the Infectious Diseases Society of America.2 This requirement may be onerous for patients who need to travel a long distance to a health care facility or physician’s office to ...
... medically supervised setting is advocated by most health care professionals, as reflected in the 2004 practice guidelines of the Infectious Diseases Society of America.2 This requirement may be onerous for patients who need to travel a long distance to a health care facility or physician’s office to ...
Presentation Slides Part 2
... Concomitant atrial fibrillation precludes accurate assessment of diastolic function Evidence of impaired systolic/diastolic function doesn’t necessarily imply that the patient has clinical HF Nuclear medicine testing with MUGA or MIBI may be a useful alternate mechanism for assessing LVEF ...
... Concomitant atrial fibrillation precludes accurate assessment of diastolic function Evidence of impaired systolic/diastolic function doesn’t necessarily imply that the patient has clinical HF Nuclear medicine testing with MUGA or MIBI may be a useful alternate mechanism for assessing LVEF ...